MtDNA‐depleted neuronal cell transcriptomes reveal Alzheimer's disease‐related changes
Open Access
- 26 November 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (11) , e70929
Abstract
INTRODUCTION: We determined whether mitochondrial DNA (mtDNA) depletion induced Alzheimer's disease (AD)‐relevant transcription changes. METHODS: Following RNA sequencing (RNA‐seq), we identified differentially expressed genes (DEGs) between SH‐SY5Y or NT2 mtDNA‐depleted (ρ0) and intact (ρ+) cell lines and quantified concordant DEG changes. Gene set enrichment analysis and over‐representation analysis were used to determine the impact on the Kyoto Encyclopedia of Genes and Genomes (KEGG) AD and other neurodegenerative disease pathways, ascertain pathway and term enrichment in the Reactome and Gene Ontology databases, and generate Ingenuity Pathway Analysis z ‐scores. RESULTS: Relative to their ρ+ comparators, ρ0 lines differentially expressed >75% of their genes. The KEGG AD pathway was significantly enriched, and equivalently altered genes ranked the AD, Parkinson's disease, ALS, and Huntington's disease KEGG pathways among the most enriched gene sets. AD‐related enriched pathways and terms reflected lipid, insulin signaling, synapse, inflammation/immune response, endosome/endocytosis, RNA, and proteostasis biology. CONCLUSION: MtDNA depletion alters gene expression in ways that recapitulate or predictably promote AD molecular phenomena. Highlights: MtDNA‐depleted neuronal cell lines reshuffle nuclear gene expression. The KEGG AD pathway is enriched with DEGs. Transcription‐defined pathways and terms relating to AD biology broadly change.Keywords
This publication has 76 references indexed in Scilit:
- Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?Journal of Alzheimer’s Disease, 2005
- The role Acyl-CoA thioesterases play in mediating intracellular lipid metabolismProgress in Lipid Research, 2002
- Faculty Opinions recommendation of ATP is required at an early step in compensatory endocytosis in synaptic terminals.2001
- Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein ImmunohistochemistryBrain Pathology, 2000
- Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activityNature, 1999
- Cybrids in Alzheimer's disease: A cellular model of the disease?Neurology, 1997
- Creation and Characterization of Mitochondrial DNA‐Depleted Cell Lines with “Neuronal‐Like” PropertiesJournal of Neurochemistry, 1996
- Staging of alzheimer's disease-related neurofibrillary changesNeurobiology of Aging, 1995
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Synaptophysin and synapsin I as tools for the study of the exo-endocytotic cycleCell Biology International Reports, 1989